Navigation Links
NCH partners with Silicon Valley to market high-end diagnostic and medical research software
Date:10/30/2012

The latest significant biomedical informatics technology is not coming from the biotech industry or a university. In fact, it's coming from a children's hospital.

Nationwide Children's Hospital in Columbus, Ohio, and Transformatix Technologies, Inc., in Davis, California, have partnered to create BioLinQ, a new biomedical informatics company designed to supply advanced software solutions for disease diagnosis and medical research.

"Years of development at Nationwide Children's Hospital funded in part by the National Institutes of Health have laid the foundation for very mature, high-end solutions in digital pathology, biospecimen analysis and biorepository management," says Ken Murray, founder and CEO, Transformatix Technologies, Inc. "With the growth of molecular technology and the advent of personalized medicine, BioLinQ is poised to have a significant impact upon the diagnostic and research capabilities in hospitals, academic research centers and the pharmaceutical industry."

The vision of the late Stephen J. Qualman, MD, who developed the Biopathology Center at Nationwide Children's, provided the foundation to advance the hospital's capabilities in the field of pathology, as well as biobanking and sophisticated digital analysis. Software solutions developed at Nationwide Children's answer the needs for highly defined biospecimen analysis, workflow management, long-distance collaboration and efficient management of laboratory and biorepository functions.

"We are seeing, with the implementation of our software, the optimization of the scientific review process for translational research. The solutions also provide visualization into the multiple dynamics of clinical trial data to aid in clinical study design," explains Dave Billiter, director, Informatics, The Research Institute at Nationwide Children's Hospital. "For example, we have a cancer consortium which called for patients to receive rapid review in order to qualify for a specific trial. Because we had this powerful suite of software, we were able to quickly accommodate the consortium and more importantly enroll the patients in the study."

Functionalities encompassed in the BioLinQ suite of solutions include:

  • A web-based software solution combining the operation and pathology workflow functionality with a backend database to manage and support the use of digital pathology and virtual microscopy. This solution provides workflow management, image viewer, and image file format conversion capabilities using an advanced imaging framework.
  • A high-end web-based software solution supporting the data chain of custody from acquisition of a consented patient sample to the testing laboratory and through complex analysis. This solution was built with advanced programmatic techniques, with an easy-to-use data storing, organizing, and manipulating program. It combines disparate data sources throughout a research study in a scalable, structured fashion, regardless of an investigator's physical location. The solution also provides a scientific dashboard and interactive query.
  • A web-based solution supporting laboratory information management activities. It provides the functional best practices in managing a biorepository, whether the repository is advanced or early-stage. This solution provides the capabilities to track a specimen throughout its repository chain of custody with full reporting and audit trail functionality.


'/>"/>

Contact: Erin Pope
Erin.Pope@NationwideChildrens.org
614-355-0495
Nationwide Children's Hospital
Source:Eurekalert

Related biology news :

1. Immune system fighters speak in patterns of proteins, prefer squishy partners
2. British Ecological Society partners with Wiley open access journal Ecology and Evolution
3. DARPA director: Revolutionary weapons require strong S&T partnerships
4. Partnership enhances biology teaching at California community colleges
5. ShanghaiBio Corporation Partners with Ingenuity Systems to Address Challenges in Analysis and Interpretation of Genomics Data
6. MU celebrates $5 million partnership for advancing biomedical discoveries
7. BGI partners with the University of Birmingham
8. Sandia seeks commercial partners for revolutionary SpinDx medical diagnostic tool
9. F1000 Research partners with figshare to provide smart ways of accessing data
10. Royal Astronomical Society and Oxford University Press partnership announced
11. Grants add to Northwestern-Qatar partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a ... most common and aggressive adult brain cancer—announced today the appointments of its first ... charged with supporting the organization’s initiatives and overall vision. , "Senior Fellows are ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... development services, today announced that the company has received ISO9001:2015 certification for ... diagnostics, and research industries. The decision to pursue ISO9001 accreditation demonstrates Kemp’s ...
(Date:6/23/2020)... ... ... In its June 22 online post, business and technology news platform Superb Crew reported ... director of stem cell biotechnology company Asymmetrex . Superb Crew decided to highlight ... it would begin offering free tissue stem cell counting at its company ...
Breaking Biology News(10 mins):
(Date:5/30/2020)... ... May 29, 2020 , ... Medrio, Inc., ... animal health markets, has enabled Cytovale, Inc., a medical technology company dedicated to ... to achieve their first patient in (FPI) in just seven days. The Cytovale ...
(Date:5/26/2020)... ... , ... Brilliant , the leading smart home control and lighting company, ... a new integration to bring more convenience, simplicity, and security to the smart home ... can now be controlled from Brilliant’s in-wall touchscreen control panels and mobile app. ...
(Date:5/21/2020)... REDWOOD CITY, Calif. (PRWEB) , ... May 20, ... ... to announce the addition of Simon Prakash, who will serve as the company’s ... Simon joins at a time when Exo is disrupting the medical imaging space, ...
(Date:5/15/2020)... ... , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to ... Ganz will continue to lead Sentien’s Board of Directors, a role he has filled ... and Sentien’s management team. , Mr. Ganz has more than 30 years ...
Breaking Biology Technology: